Insights into the regulatory characteristics of the mycobacterial dephosphocoenzyme A kinase: implications for the universal CoA biosynthesis pathway by Walia, Guneet & Surolia, Avadhesha
Insights into the Regulatory Characteristics of the
Mycobacterial Dephosphocoenzyme A Kinase:
Implications for the Universal CoA Biosynthesis Pathway
Guneet Walia1, Avadhesha Surolia1,2*
1Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India, 2National Institute of Immunology, New Delhi, India
Abstract
Being vastly different from the human counterpart, we suggest that the last enzyme of the Mycobacterium tuberculosis
Coenzyme A biosynthetic pathway, dephosphocoenzyme A kinase (CoaE) could be a good anti-tubercular target. Here we
describe detailed investigations into the regulatory features of the enzyme, affected via two mechanisms. Enzymatic activity
is regulated by CTP which strongly binds the enzyme at a site overlapping that of the leading substrate,
dephosphocoenzyme A (DCoA), thereby obscuring the binding site and limiting catalysis. The organism has evolved a
second layer of regulation by employing a dynamic equilibrium between the trimeric and monomeric forms of CoaE as a
means of regulating the effective concentration of active enzyme. We show that the monomer is the active form of the
enzyme and the interplay between the regulator, CTP and the substrate, DCoA, affects enzymatic activity. Detailed kinetic
data have been corroborated by size exclusion chromatography, dynamic light scattering, glutaraldehyde crosslinking,
limited proteolysis and fluorescence investigations on the enzyme all of which corroborate the effects of the ligands on the
enzyme oligomeric status and activity. Cysteine mutagenesis and the effects of reducing agents on mycobacterial CoaE
oligomerization further validate that the latter is not cysteine-mediated or reduction-sensitive. These studies thus shed light
on the novel regulatory features employed to regulate metabolite flow through the last step of a critical biosynthetic
pathway by keeping the latter catalytically dormant till the need arises, the transition to the active form affected by a
delicate crosstalk between an essential cellular metabolite (CTP) and the precursor to the pathway end-product (DCoA).
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Introduction
More than a century, a vaccine and several chemotherapeutic
agents later, Mycobacterium tuberculosis continues its deadly march
claiming several thousand lives each year [1,2]. With mycobac-
teria investing a major part of their coding capacity towards fatty
acid synthesis, there being a whopping 250 distinct enzymes
involved in fatty acid metabolism and 9% of all cellular activities
employing Coenzyme A (CoA) as a cofactor (BRENDA
database), targeting the tubercular CoA biosynthesis holds
potential in globally impairing the pathogen, as CoA is involved
in a variety of critical cellular processes, the chief being the
synthesis of the cell wall mycolic acids [3]. This ubiquitous,
indispensable cofactor, along with its precursor, 49-phosphopan-
tetheine (prosthetic group incorporated by carrier proteins),
functions as an acyl group carrier and carbonyl-activating group
for Claisen reactions as well as for amide-, ester-and thioester-
forming reactions in the cell [4]. CoA and its thioesters
participate directly in the biosynthesis of five amino acids and
indirectly in macromolecular biosynthesis through glutamate
synthesis via the tricarboxylic acid cycle [5]. CoA is an important
metabolite for cellular growth demonstrated by the fact that a
fall in its concentration below 5 pmol/108 cells leads to growth
stasis [6]. The choice of the CoA biosynthetic pathway for
investigation is lent credence by the fact that this pathway is
essential in a majority of the prokaryotic pathogens, any
deletions leading to growth stasis or lethality. The fact that
these organisms are unable to take up either CoA or the
phosphorylated reaction intermediates exogenously further
corroborates the choice of this pathway as a potential drug
target. Interestingly, evolutionary evidence points out that this
universal biosynthetic pathway branched out early during the
evolutionary history of life on earth and the present day
eukaryotic and prokaryotic CoA-synthetic machinery differs
vastly, with major differences in the basic architecture of the
pathway and the regulation of individual steps [7].
Considering the plethora of critical roles this cofactor plays,
regulation of its biosynthetic pathway has been under scrutiny
for a long time. Even before the mechanistic details of the first
enzyme of the CoA pathway were known, it was demonstrated
that this step forms an important regulatory site of the
biosynthetic pathway being potently feedback regulated by the
end-product of the pathway and to a lesser extent, by its
thioesters [6,8]. This enzyme, Pantothenate kinase (CoaA), a
homodimer, follows a compulsory ordered mechanism with ATP
as the first substrate [9]. The mode of the CoA-effected
inhibition was demonstrated by Yun et al. who showed that
CoA binds the enzyme at a site similar to that occupied by the
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phosphate donor, ATP, therefore competitively inhibiting
pantothenate kinase [10].
The penultimate enzyme of the biosynthetic pathway, 49-
phosphopantetheine adenylyltransferase, CoaD, has also been
implicated in the regulation of the universal CoA biosynthesis.
Geerlof et al. demonstrated that purified E. coli CoaD co-elutes
with 0.5 mole of CoA per mole of the enzyme [11]. Rubio et al.
demonstrated that the Arabidopsis thaliana CoaD plays a critical role
in plant growth, salt/osmotic stress resistance and seed lipid
storage [12]. Thus the five-step Coenzyme A biosynthesis pathway
has been shown to be regulated at its first step, CoaA and at the
penultimate step, CoaD.
The importance of CoA in central metabolism and the vast
differences in its biosynthesis in prokaryotic pathogens and
eukaryotic hosts have prompted the design and testing of several
inhibitors against the individual enzymes of the prokaryotic CoA
biosyntheses. A majority of these inhibitors have targeted the two
known regulatory steps of the pathway, those catalyzed by CoaA
and CoaD. Several structural analogues of the substrate for CoaA,
pantothenate, obtained mostly through the modification of the b-
alanine moiety of pantothenic acid, for example, replacement of
the carboxylic acid group with a sulphonic acid, N-substituted
sulphonamide, thiol, disulphide, sulphone, alcohol, ketone, N-
substituted amide, N-substituted carbamate or an N-substituted
ureido group have shown varied antibacterial effects [13].
Analogues of 49-phosphopantetheine, the substrate for CoaD,
have also shown potent inhibition of the enzyme, however, these
did not show effective antibacterial activity as they could not cross
the membrane barrier [14]. Therefore, careful design of
compounds inhibiting the enzymes of the mycobacterial CoA
biosynthesis hold potential for future drug development against
tuberculosis.
Not many studies have been undertaken so far to distinguish the
role of the last enzyme of the pathway, dephosphocoenzyme A
kinase, which ultimately generates the cofactor CoA, in the
regulation of metabolite flow through this critical pathway. In view
of the unique characteristics of the mycobacterial enzyme in terms
of its kinetic properties compared to its bacterial and eukaryotic
counterparts, it was interesting to examine the regulation of this
catalytic activity. Further, considering the fact that the tubercular
pathogen invests a majority of its biosynthetic capability in lipid
metabolism for which CoA is a critical cofactor, the pathogen
potentially employs novel mechanisms to regulate CoA production
in tune with its fastidious requirements for this cofactor and its
thioesters [15,16]. We have previously demonstrated that the last
enzyme of mycobacterial CoA biosynthesis is inhibited by the
cellular metabolite CTP [17]. Our previous docking analyses
further provided an insight into the potential mode of this
inhibition, with the enzyme’s leading substrate, DCoA and CTP
interacting with some common residues on the enzyme and
potentially occupying overlapping binding sites on mycobacterial
CoaE [17]. Here we elucidate the elegant mechanism employed
by this oldest known infectious agent to effect regulation at the last
step of the biosynthesis of a critical enzymatic cofactor, entailing a
dynamic interplay between the monomeric and trimeric states of
the enzyme, effected by the interaction of CoaE with its leading
substrate, DCoA and inhibitor, CTP.
Materials and Methods
CTP inhibition assays
The kinetic/biochemical activity of the mycobacterial depho-
sphocoenzyme A kinase was evaluated in the presence of CTP by
the spectrophotometric and isothermal titration calorimetric assays
described in [17]. For the inhibition assays, the enzyme was pre-
saturated with 1 mM CTP for 20 mins before initiating catalysis.
For the single-coupled spectrophotometric assay, the reaction mix
contained Tris (50 mM), MgCl2 (10 mM), a´-ketoglutarate dehy-
drogenase, NAD (0.3 mM), ATP (1 mM), a´-ketoglutarate (4 mM)
and thiamine pyrophosphate (1 mM).
CoaE specific activity assays
The specific activity of the mycobacterial CoaE was assessed by
the double-coupled pyruvate kinase-lactate dehydrogenase (PK-
LDH) assay system described in [17]. The assay mixture contained
DCoA (0.5 mM), ATP (1 mM), MgCl2 (10 mM), PEP (0.8 mM),
NADH (0.3 mM), 50 mM Tris, pH 8.0 and PK-LDH. In order to
distinguish the more active species between the trimeric and
monomeric forms, the specific activity was measured as a function
of enzyme concentration using a range of CoaE concentrations
(10 nM–10 mM) at a fixed DCoA concentration (0.5 mM). In
order to evaluate the effect of CTP on the specific activity, the
enzyme was saturated with 1 mM CTP for 20 mins prior to
activity measurements. Enzymatic velocity vs. substrate concen-
tration plots were also plotted using parameters determined by the
double-coupled spectrophotometric assay.
Size exclusion chromatographic analysis
Oligomeric status of the mycobacterial CoaE was determined
by size exclusion chromatography (SEC) of 100 mM protein on a
SuperdexTM200 HR106300 mm column attached to a fast
pressure liquid chromatography system (Amersham Pharmacia).
The flow rate was maintained at 0.2 mL/min and the absorbance
was recorded at 280 nm. SEC was carried out in the presence and
absence of 1 mM ATP, DCoA, CoA, CTP, acetyl-CoA, butyryl-
CoA, malonyl-CoA, succinyl-CoA, b-hydroxybutyryl-CoA and
crotonoyl-CoA. Prior to the mycobacterial CoaE experiments, the
column was calibrated with lysozyme (14 kDa), carbonic anhy-
drase (29 kDa), ovalbumin (45 kDa), bovine serum albumin
(66 kDa) and aldolase (158 kDa).
Analysis by Dynamic Light Scattering (DLS)
DLS studies were performed for the mycobacterial depho-
sphocoenzyme A kinase on a DynaPro Dynamic Light Scattering
instrument. The protein sample (2 mg/mL) in 20 mM Tris,
150 mM NaCl, 10% glycerol (pH 7.8) was centrifuged at
14,000 rpm for 25 min prior to taking measurements. Dynamics
V6 software was used to calculate the hydrodynamic radius of
mycobacterial CoaE.
Glutaraldehyde crosslinking of CoaE
To avoid a decrease in the crosslinking yield due to the
interaction of the Tris amino groups with glutaraldehyde, CoaE
was dialyzed overnight in 1X PBS, pH 7.8. A Ni-NTA agarose
resin of 1 mL final volume was specifically packed and
equilibrated with Buffer A (10 mM imidazole, 50 mM NaCl,
50 mM phosphate buffer, pH 8.0) for the crosslinking experi-
ments. CoaE (500 mg) was prepared in Buffer A. 4 mL of the
sample was then slowly applied to the column. Upon protein
binding, the column was washed with 8 mL of Buffer A and 8 mL
of Buffer B (50 mM NaCl, 50 mM phosphate buffer, pH 8.0).
Glutaraldehyde (2.5 mL) prepared to a final concentration of
0.05% (v/v) in Buffer B was added to the column and allowed to
flow through by gravity. The crosslinking reaction was then
quenched with 8 mL of 0.5 M Tris/HCl, pH 8.0. Buffer C (8 mL)
(300 mM imidazole, 50 mM NaCl, 50 mM phosphate buffer,
pH 8.0) was then used to elute the bound crosslinked protein [18].
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The covalent oligomers were then resolved on an 8% SDS–PAGE.
All steps were carried out at room temperature.
Cloning, expression and purification of the CoaE cysteine
mutants, C235S and C368S
Utilizing the primers, C235S_Fwd: 59 –GATCGCGTCCGGG-
CATAAGGCCTTG- 39 and C235S_Rev: 59 –ATGCCCGGAC-
GCGATCTTTAG- 39 and the set, C368S_Fwd: 59 –GAAGAC-
TATTTGACGGTCAAGTCTGACGCCGACAG- 39 and C36-
8S_Rev: 59-GTCGGCGCGCCTGTCGGCGTCAGACTTGA-
CC- 39, the CoaE cysteine mutants, C235S and C368S, were
PCR-amplified from the mycobacterial genomic DNA using the
same conditions as the wild type protein described in [17]. The
cysteine mutant proteins were expressed and purified like wild type
CoaE [17,19].
Effects of reducing agents on CoaE oligomerization
The effect of a range of DTT concentrations (20 mM–20 mM)
and two b-ME concentrations (2 mM and 10 mM) was scanned on
purified mycobacterial CoaE, its active site mutants (D33E,
L113A, K14A) and cysteine mutants (C235S, C368S) at 20ı`g
concentrations in 50 mL reactions [15]. Each enzyme was
incubated with the reducing agents over a range of time periods
(109, 209, 309, 459 and 60 mins) in order to assess if prolonged
incubation has any effect on the oligomeric status. In two different
sets of reactions, CoaE was pre-incubated with 1 mM DCoA and
1 mM CTP for 30 mins before incubation with the reducing
agents to determine the protection afforded by these metabolites
on the enzyme towards disulphide-reduction. Upon reduction, a
range of H2O2 concentrations (50 mM–20 mM), incubated with
the reduced enzyme for 30 mins, were also scanned to study
reduction-reversal. The oligomeric status of the reaction products
was then evaluated by the addition of non-reducing Laemmli
SDS-PAGE buffer, sample boiling for 5 min and separation on an
8% non-reducing SDS-PAGE and a 8% Native PAGE. Both gels
were Coomassie-stained. Further confirmation of the results was
obtained by Western blotting of the gels with anti-His antibodies.
Limited proteolysis of mycobacterial
dephosphocoenzyme A kinase
The mycobacterial enzyme was subjected to proteolytic
cleavage with three different proteases, trypsin, chymotrypsin
and subtilisin. 4 ng/mL of trypsin was used to cleave 10 mM of the
enzyme at 25uC. Prior to incubation, the master mix was
subdivided into individual aliquots, one of which was withdrawn
at fixed time intervals. The proteolytic reaction was monitored for
180 minutes and one sample was incubated overnight at 25uC.
These samples were resolved on an 8% SDS gel which was
Coomassie-stained to assess the fragmentation pattern. To study
the protection afforded by the ligands on the enzyme, ATP,
DCoA, CoA and CTP were incubated with the mycobacterial
CoaE for 30 mins on ice, prior to the addition of trypsin.
Fluorescence emission analysis of CoaE
Fluorescence measurements were performed on a JobinYvon
Horiba fluorimeter, exciting the proteins at 295 nm and recording
the fluorescence emission from 300–450 nm. The excitation and
emission monochromator slit widths were 2.5 nm and 5 nm,
respectively. The proteins were dialyzed in 1X PBS and 5%
glycerol and were used at concentrations of 5–10 mM. Measure-
ments were done in a 100 mL quartz cuvette. Spectra were
corrected for background fluorescence (almost negligible) from the
buffer, DCoA and CTP in all experiments.
Results
The role of CTP in the regulation of CoaE activity
As previously demonstrated, of all the phosphate donors tested
for the mycobacterial CoaE, CTP bound the enzyme the most
tightly [17]. However, this nucleotide did not participate in
catalysis. Following up on the lead of strong binding of CTP to the
enzyme, its effect on CoaE activity and catalysis was further
examined. As shown in Figure 1A, pre-incubation of the
mycobacterial CoaE with different concentrations of CTP resulted
in an inhibition of the enzymatic reaction, pre-incubation with
1 mM CTP causing a decline in activity to about 16% of that seen
in its absence. A Michealis-Menten V vs. [S] plot of the velocity of
the CoaE enzymatic reaction vs. a range of DCoA concentrations
in the presence and absence of CTP (1 mM) is shown in Figure 1B.
The role of the oligomeric status of CoaE in its regulation
The mycobacterial dephosphocoenzyme A kinase belongs to the
P-loop containing nucleoside monophosphate kinase family
(NMPK) of the nucleoside triphosphate hydrolases superfamily,
majority members of which are structurally very similar despite
sharing very low sequence homology. The crystal structures solved
for the three bacterial CoaEs till date give evidence for a
monomeric state for the enzymes with the E. coli enzyme (being a
monomer in solution) having crystallized as a crystallographic
trimer due to the presence of sulphate in the crystallization buffer
[20]. Considering the unique properties of the mycobacterial
CoaE and its differences from the other dephosphocoenzyme A
kinases, its oligomeric status was studied.
Analysis by Size-Exclusion Chromatography
The oligomeric equilibrium of the native enzyme. On a
Sephadex-200 column, the native protein eluted as a mixture of 2
peaks of approximately similar abundance, which were assigned as
a trimer (Mr ,141,0006150 Da, peak 1) and a monomer (Mr of
,47,0006150 Da, peak 2) (on the basis of the position of the
elution peaks of proteins used as standards to calibrate the column)
with a trimer: monomer ratio of 1:(0.932) (Figure 2A). Since such
an equilibrium between two oligomeric states has not been
reported for any other dephosphocoenzyme A kinase, the role of
this unique feature of the mycobacterial enzyme was explored
further.
The effect of the leading substrate, dephosphocoenzyme
A. The effects of DCoA on the oligomerization of the enzyme
were explored through gel filtration. Interestingly, when the native
protein was incubated with DCoA for 30 mins at 4uC and then
run on the column, a consistent marked increase in the abundance
of the monomeric peak with a consequent decrease in the trimeric
peak intensity was observed; the trimer: monomer ratio now being
1:(2.14) (Figure 2A). This significant shift from the trimeric to the
monomeric state was again observed when the eluted trimeric
peak was collected, incubated with DCoA and re-injected (as seen
in five independent experiments). In order to evaluate the effect of
the second substrate, ATP, on the re-adjustment of the oligomeric
equilibrium of the mycobacterial CoaE, the enzyme was incubated
with the phosphate donor for 30 mins before gel filtration.
Surprisingly, pre-incubation with ATP did not have any effect
on the distribution of the enzyme between the two oligomeric
states (Figure 2A). The failure of ATP to effect any change in the
oligomeric status of the enzyme can be explained in the light of the
fact that ATP binds the enzyme well only when the enzyme is a
priori saturated with DCoA [17].
In order to rule out the above-mentioned re-equilibration of the
oligomeric states as a non-specific consequence of the interaction
Regulation of Mycobacterial CoaE
PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e21390
of the enzyme with an analog of CoA or its thioesters, the enzyme
was separately incubated with 1 mM each of acetyl-CoA, malonyl-
CoA, crotonoyl-CoA, succinyl-CoA and -hydroxybutyryl-CoA
and run on the S-200 column. None of the CoA thioesters elicited
a response remotely similar to that observed with DCoA, as CoA
or its thioesters did not alter the oligomerization status of CoaE. A
representative curve with malonyl-CoA is shown in Figure 2B
where the trimer: monomer ratio is 1:(1.01), similar to that of the
native enzyme. Therefore the aforementioned effect of DCoA on
the enzyme’s oligomeric status is not a non-specific consequence
effected by any CoA species but is an effect of the interaction of the
leading substrate with the enzyme.
The effect of the inhibitor, CTP, on the CoaE oligomeric
status. The mechanism of CTP inhibition of the mycobacterial
CoaE activity was further probed by exploring whether this
inhibition in any way translated into a shift in the oligomeric
status. Pre-incubating CoaE with 1 mM CTP alone showed a
trimer: monomer ratio of 1:(0.614) as against a ratio of 1:(0.932)
observed for the native CoaE (Figure 2B). Significantly, pre-
incubation of the enzyme with 1 mM CTP, prior to its incubation
with DCoA, prevents the DCoA-mediated CoaE transition from a
trimeric state to the monomer, with 38% of the enzyme eluting as
a monomer in the presence of both CTP and DCoA as against
70% of the monomer in the presence of DCoA (Figure 2B). Thus,
the transition of the enzyme from its potentially inactive, trimeric
state to its active, monomeric form, originally effected by the
leading substrate, DCoA, is prevented by pre-incubation with
CTP.
Analysis by Dynamic Light Scattering
A further confirmation of the enzymatic transitions of CoaE in
the presence of the ligand effectors was obtained by carrying out
DLS measurements on the enzyme which revealed three distinct
populations visualized as three peaks in the histogram, corre-
sponding to the monomer (2.8 nm radius), the trimer (5.7 nm
radius) and a non-specific aggregate (a radius of 30 nm and above)
respectively with the aggregate being the most thinly populated,
forming a mere 5–7% of the protein population distributed in the
three states. The aggregate was not observed in many DLS
experiments. An increase in the intensity of the monodisperse peak
Figure 1. Effects of CTP on CoaE enzymatic activity. (A), Histogram depicting the percent decrease in CoaE activity in the presence of CTP, with
the activity of CoaE in the presence of ATP (1 mM) and DCoA (0.5 mM) treated as 100% (Lane 1). Lanes 2–6 show the percent activity of CoaE in the
presence of different concentrations of CTP; Lane 2, 50 mM CTP; Lane 3, 100 mM CTP; Lane 4, 250 mM CTP; Lane 5, 500 mM CTP; Lane 6, 1 mM CTP. (B),
CoaE reaction velocity plotted versus leading substrate, DCoA concentrations (10–640 mM) in the presence and absence of CTP (1 mM), measured
using the coupled PK-LDH spectrophotometric assay.
doi:10.1371/journal.pone.0021390.g001
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corresponding to the monomer with a hydrodynamic radius of
2.8 nm when the enzyme was pre-incubated with DCoA was
observed. Moreover, these DLS data also corroborate the
influence of CTP on the oligomerization status of CoaE as
elucidated above by SEC, demonstrating that CoaE pre-
incubation with CTP shows a similar distribution of the peaks as
those of the native enzyme alone.
Glutaraldehyde crosslinking of the mycobacterial CoaE
Glutaraldehyde crosslinking experiments on CoaE further
confirmed the presence of the enzymatic trimer through the
appearance of a band of ,140 kDa corresponding to the trimeric
molecular mass of the mycobacterial CoaE (Figure 3).
Effects of reducing agents on the oligomeric status
The mycobacterial CoaE has three cysteine residues and the
final confirmation of its oligomeric re-equilibration was obtained
by ruling out a cysteine-mediated covalent oligomerization of
CoaE. The lack of reduction-sensitivity of the oligomerization and
the absence of any effect of Cys-Ser mutagenesis (C235S, C368S)
confirmed that CoaE oligomerization was not a disulphide-
mediated covalent process.
CoaE specific activity assays
The equilibrium distribution of an enzyme in various oligomeric
states is affected by the enzymatic concentration. Therefore,
dilution of the enzyme is bound to have an effect on its specific
activity as the change in enzyme concentration will reflect in the
distribution of the enzyme in the active and inactive species. Thus,
in order to conclusively identify the active form of the
mycobacterial CoaE among the two oligomeric states and gain
an insight into the form that is potentially active physiologically,
the specific activity of the enzyme was studied as a function of
CoaE concentration (10 nM–10 mM), keeping the concentration
of the leading substrate DCoA constant (0.5 mM). It is interesting
to note that CoaE showed a higher specific activity at low enzyme
concentrations i.e. as the enzyme concentration decreases, the
addition of a fixed concentration of DCoA brings about a
consistent increase in the specific activity, demonstrating that the
monomer is the active species (Figure 4A). Thus, the monomeric
form of the mycobacterial CoaE is, in all probability, the active
form of the enzyme in the cell. Further, the effect of CTP on
catalysis was assessed by incubating the enzyme with 1 mM CTP
which resulted in a decrease in the values of the specific activity
measured at lower CoaE concentrations, this effect being apparent
when the enzyme was most dilute (Figure 4A). It should be noted
that the reaction mixture for the assay was compensated
appropriately each time the enzyme was diluted in the presence
of CTP so as to maintain the final CTP concentration constant at
1 mM. This assay is only limited by the range of enzyme
concentrations tested viz., the inability to record catalysis at low
concentrations due to a reduced sensitivity of product detection
and the complexity in maintaining initial rate conditions at high
enzyme concentrations. Further, a Dixon plot (1/V vs. [I = CTP]
at different [S = DCoA] assigned a Ki value of 34 mM to this
unique metabolic inhibitor, CTP (Figure 4B) which shows
competitive inhibition of mycobacterial CoaE. It is interesting to
note that the Ki is quite similar to the affinity of the enzyme (Km)
for its leading substrate, DCoA [17].
Ligand-induced conformational changes in CoaE. In
order to ascertain how the effects of the ligands, DCoA and
Figure 3. The on-column glutaraldehyde crosslinking of the mycobacterial CoaE. The 8% SDS-PAGE gel picture shows the CoaE protein
loaded on the column (Load); the flowthrough from the column during loading (FT), the eluate during the wash steps (WI, WII and WIII); the
molecular weight marker (M) and the elution aliquots (E1 and E2).
doi:10.1371/journal.pone.0021390.g003
Figure 2. Determination of the oligomeric status of CoaE by size exclusion chromatography. (A), Each individual reaction mixture,
incubated for 30 mins, contained CoaE alone; CoaE+1 mM DCoA; CoaE+1 mM ATP+1 mM MgCl2 was loaded on a Superdex S-200 column. (B), Each
individual reaction mixture, incubated for 30 mins, contained CoaE+1 mM DCoA; CoaE+1 mM CTP (incubated for 30 mins) + DCoA (incubated for
another 30 mins); CoaE+ 1 mM Malonyl-CoA. Peak 1: Trimeric CoaE (Mr ,140,00062900 Da), Peak 2: Monomeric CoaE (Mr ,47,000615 Da)
(Molecular masses expressed as mean 6 S.D. of five independent experiments).
doi:10.1371/journal.pone.0021390.g002
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CTP, on the catalytic activity and oligomeric equilibrium actually
translate into changes in the gross secondary and tertiary structure
of the enzyme, two different approaches were employed.
Limited Proteolysis of the mycobacterial CoaE. Limited
proteolysis helps study the change in the accessibility of scissile
peptide bonds, thereby shedding light on the mechanisms of
enzymatic catalysis and regulation. Thus, to study the effects of the
leading substrate, DCoA and the inhibitor, CTP on the enzyme in
terms of gross conformational changes effected, the protection
afforded by these ligands upon the enzyme during limited
proteolysis studies was analyzed. Mycobacterial CoaE was
proteolyzed by three different proteases, trypsin, subtilisin,
chymotrypsin, under limiting conditions at a protease to protein
ratio of 1:50 (w/w). Although CoaE has 46 theoretical tryptic
cleavage sites, upon digestion with trypsin only a limited number
of fragments were generated (Figure 5A and D).
Protection afforded by DCoA during proteo-
lysis. Proteolysis of 10 mM CoaE in the presence of 300 mM
DCoA demonstrated that DCoA stabilizes an ,34 kDa
proteolyzed fragment (Figure 5B) as late as 120 mins post-
incubation with the protease. By virtue of DCoA binding to
the N-terminal domain of the bi-domain mycobacterial CoaE,
this ,34 kDa fragment is in all possibility the NTD of the
enzyme. It is interesting to note that this particular fragment
does not persist in the tryptic digest of the native enzyme alone,
with the band for this fragment disappearing totally between 60–
Figure 4. Inhibition kinetics. (A), Measurement of the specific activity of CoaE as a function of enzyme concentration. Freshly prepared CoaE was
diluted in buffer alone or was pre-saturated with 1 mM CTP and diluted in buffer+CTP to a range of concentrations (10 nM–10 mM) and activity was
measured at 0.5 mM DCoA. (B), Dixon plot (1/V vs. [CTP]) illustrating the inhibition of the mycobacterial dephosphocoenzyme A kinase by CTP
(Ki = 34 mM), at three different concentrations of the leading substrate, DCoA.
doi:10.1371/journal.pone.0021390.g004
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75 mins upon incubation with trypsin. Thus, DCoA binding to
mycobacterial CoaE possibly induces conformational changes in
the enzyme which obscure the scissile bond previously available
for tryptic cleavage protecting the enzyme from proteolytic
digestion.
Protection afforded by CTP during proteolysis. It is
interesting to note that limited proteolysis of the mycobacterial
CoaE (10 mM) in the presence of the regulator, CTP (1 mM),
yields a similar fragmentation pattern as observed in the presence
of DCoA (Figure 5C). CTP also protects the same fragment from
further proteolysis as was seen with DCoA, with the band
persisting up to 120 mins in the presence of CTP as against a mere
60–75 mins in the native enzyme digestion. Thus, CTP affords
similar protection on the mycobacterial enzyme as the leading
substrate, hinting at a similar site of binding of the two substrates.
Fluorescence studies on CoaE. The mycobacterial CoaE
possesses 11 tryptophan residues which can therefore be employed
to study the overall conformational changes induced upon DCoA
and CTP binding. In the absence of any ligand, the emission
spectrum is a broad peak with an emission maximum centered at
337.5 nm when it is excited at 295 nm (Figure 6 inset). The Lmax
of a comparable concentration of L-Trp solution was 355 nm. The
blue-shifted Lmax in CoaE indicated that the tryptophan residues
are on average in a nonpolar (hydrophobic) environment. Though
increasing concentrations of DCoA show no effect on the
tryptophan emission spectrum of 10 mM CoaE at pH 7.8
(Figure 6 inset), saturating concentrations of CTP cause a
quenching of fluorescence indicating a decreased exposure to the
solvent of the tryptophan residues in the enzyme-ligand (CoaE-
CTP) complex (Figure 6). Thus, CTP binding induces
Figure 5. Limited proteolysis of the mycobacterial CoaE studied by tryptic cleavage at various time points and separation of the
digestion products on an 8% SDS-PAGE gel. (A), tryptic digestion fragmentation pattern for CoaE. (B), protection afforded by the leading
substrate, DCoA, on the mycobacterial enzyme during proteolysis. (C), fragmentation pattern of CoaE digestion in the presence of CTP. (D),
Comparison of the cleavage patterns of CoaE alone and that in the presence of DCoA. (-Tryp) denotes the enzyme aliquot in the absence of the
protease.
doi:10.1371/journal.pone.0021390.g005
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conformational changes which affect the tryptophan environment
in the mycobacterial CoaE.
Discussion
Vitamin and cofactor biosynthetic pathways hold considerable
promise for anti-mycobacterial therapy. Pioneering work from the
Jacobs’ lab, for example, has shown that a Mycobacterium tuberculosis
pantothenate auxotroph (DpanC-DpanB) has impaired survival
and pathogenesis, the highly attenuated knock-out strain impart-
ing long-term protection to mice against tuberculosis [15,16]. The
CoA biosynthetic pathway, unlike that of its precursor pantothe-
nate, is a ubiquitous and essential pathway in a vast majority of
organisms. Synthesizing an essential metabolite, the flux through
this pathway is therefore very tightly regulated with each of the five
steps leading to CoA biosynthesis being regulated by multiple
mechanisms to ensure efficient utilization of cellular resources.
The last enzyme of the pathway, dephosphocoenzyme A kinase,
has surprisingly received very little attention over the past several
years and there are no reports on the regulation of this enzymatic
activity so far. Considering the fact that it is the last step that
eventually gives rise to CoA and that this enzyme from the
mycobacterial system varies strikingly from its human counterpart,
the significance of regulation of this enzyme needs no emphasis. In
this study, the molecular determinants for the oligomeric assembly
of CoaE were dissected and the role of the oligomerization status
in substrate binding, catalysis and kinetic regulation was analyzed.
CoaE belongs to the family of nucleotide and nucleoside
kinases, majority members of which are monomeric. As seen in
these studies, the native mycobacterial enzyme exists primarily as a
mixture of a trimer and a monomer of almost equal abundance
but incubation with the leading substrate, DCoA, causes a shift of
the trimer towards the monomeric state. The second substrate,
ATP, alone has no effect on the enzyme’s oligomeric status and
this is further validated by our previous ITC studies, which
demonstrate ATP’s inability to bind the enzyme in the absence of
DCoA [17]. Interestingly, the aforementioned effect of DCoA is
not a non-specific consequence effected by any CoA species as
neither CoA nor its thioesters are capable of mediating such a
change and therefore it is an unambiguous effect of the interaction
of the leading substrate with the enzyme. Further, kinetic assays
unequivocally established that the monomeric form is the more
active form of the enzyme. It can therefore be hypothesized that in
the cell, the enzyme is possibly sequestered in an inactive higher
trimeric form which gets converted to the active, monomeric form
in the presence of the leading substrate, DCoA, which then
facilitates the binding of the second substrate, ATP. This hints at a
possible regulatory mechanism the cell employs to check
production of the essential metabolite CoA by keeping the
ultimate enzyme of its biosynthetic pathway catalytically dormant
till the need arises.
The role of the dynamic interplay of the various oligomeric
states of an enzyme in its regulation is not unusual. The
mycobacterial CoaE shows behavior analogous to the key enzyme
of the mammalian sialic acid biosynthesis, UDP-N-acetylglucosa-
mine 2-epimerase/N-acetylmannosamine kinase (GNE). The
activity of GNE is regulated by a series of mechanisms; (i)
allosteric feedback inhibition by CMP-Neu5Ac, (ii) competitive
inhibition by UDP and (iii) re-equilibration of various oligomeric
states (monomers, dimers, tetramers and higher aggregates). The
Figure 6. Fluorescence studies. The effect of CTP on CoaE fluorescence depicted by a plot of the fluorescence emission intensity recorded at the
maxima of 337.5 nm versus the various concentrations of CTP used. (Inset), The effects of the ligands, DCoA, ATP and CTP on the fluorescence
emission of mycobacterial CoaE.
doi:10.1371/journal.pone.0021390.g006
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epimerase substrate, UDP-GlcNAc favors the formation of the
tetramers which is the active form in the cell, while in the presence
of the allosteric inhibitor CMP-Neu5Ac, the enzyme is in the
dimeric state. The presence of both the ligands favors a tetrameric
GNE [21]. These results are similar to those observed for the
mycobacterial CoaE. Interestingly, despite it being counter-
intuitive that monomers and not the readily-formed oligomers
(which can possibly allow structural and functional variations)
form the optimally active species, there are several examples of
enzymes which are active in their monomeric forms, such as the
rat liver UMP/CMP kinase with which the mycobacterial CoaE
shares significant homology, the purine nucleotide phosphorylase
from bovine spleen, the E. coli ribonucleoside diphosphate
reductase etc. [22]. Therefore, even though the involvement of
different oligomeric states in activity regulation has not been
investigated for the Coenzyme A biosynthesis, the suggestion that
the monomeric form of the enzyme is the most active is not
uncommon in biology.
The oligomeric re-equilibration observed for the mycobacterial
CoaE could perhaps be a universal regulatory mechanism
exploited by all dephosphocoenzyme A kinases in light of the fact
that the E. coli enzyme was crystallized as a trimer while in solution
a majority was found to exist as a monomer as were the
Haemophilus and Thermus CoaEs [20,23–24]. The E. coli crystal
structure probably captured the potentially dormant higher
oligomer in the crystal which was converted into the active
monomer in the presence of the substrate during activity analyses
by HPLC, as the authors clearly point out that ‘gel filtration and
DLS measurements on the purified protein before crystallization
indicated a monomeric state in solution’ [20]. This is further
corroborated by the fact that an analysis of the E. coli CoaE
biochemical activity in solution by HPLC in an earlier study
showed it to be a monomer [25]. It can therefore be hypothesized
that the P-loop-containing DCoA kinases which are known to
possess mobile lid and CoA domains, are maintained in the
inactive state as higher oligomers (i.e. as trimers) which limit the
mobility of the lid and CoA domains due to spatial constraints and
therefore render these oligomers incapable of catalysis by
preventing the phosphate transfer to the ever-present water
(Figure 7). These inactive oligomers are then recruited by the
cell when CoA is required. DCoA, being the leading substrate,
paves the way for the beginning of catalysis by releasing the spatial
constraints, thereby transforming the inactive trimers to active
monomers for catalysis (Figure 7) [17].
The strong binding of CTP to the mycobacterial CoaE despite
its inability to serve as a phosphate donor in the kinase reaction a
priori appears puzzling [17]. The role of this unique cellular
metabolite in the regulation of CoaE activity was therefore
investigated in detail. Similar regulation of metabolic enzymes by
NTPs other than their natural substrates is not uncommon, one
such example being reported in the pyrimidine nucleotide
biosynthesis pathway and like CoA biosynthesis is essential for
the survival of several organisms. In the E. coli pyrimidine
nucleotide biosynthesis, the hexameric uridyl monophosphate
kinase has been shown to be activated by GTP and inhibited by
UTP [26]. Further, it is interesting to note that the mycobacterial
Figure 7. Schematic depicting the dynamic interplay between the enzyme’s leading substrate, DCoA and the cellular metabolite,
CTP, in regulating the activity of the last enzyme of mycobacterial CoA biosynthesis. The enzyme is sequestered in a trimeric state that
renders it inactive, potentially due to spatial constraints imposed on the mobile lid and CoA domains. DCoA, upon binding, induces monomerization,
releasing these constraints and inducing conformational changes in the enzyme, allowing the phosphate donor, ATP, to bind and catalysis to occur.
CTP, on the other hand, prevents DCoA from binding the enzyme by virtue of occupying a similar binding site on the enzyme, thereby preventing the
oligomeric re-equilibration, reflected in a mere 16% active CoaE in the presence of 1 mM CTP. Thus the mycobacterial cell employs regulation at the
last enzyme of CoA biosynthesis via two co-acting mechanisms.
doi:10.1371/journal.pone.0021390.g007
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dephosphocoenzyme A kinase, like the bacterial uridyl mono-
phosphate kinase, also belongs to the NMPK superfamily.
Therefore, the relevance of the strong interaction of CTP with
the mycobacterial dephosphocoenzyme A kinase was explored
further. It is interesting to note that pre-incubating the
mycobacterial CoaE with CTP inhibited the kinase. These results
were clearly explained by the SEC data which show that CTP very
neatly sequesters the enzyme in the trimeric state, thereby
preventing DCoA from initiating monomerization. Therefore,
the percentage of active enzyme falls, as does the enzyme activity.
This is further corroborated by the effects of CTP seen on the
measurement of CoaE specific activity as a function of the enzyme
concentration. Docking both the metabolic inhibitor, CTP and the
leading substrate, DCoA, clearly reveals that there is an overlap in
the two binding sites on the mycobacterial CoaE thereby
explaining the inhibition shown by CTP of the activation by
DCoA and therefore the conversion of the inactive trimer to the
active monomer [17]. Therefore, the data presented here hint at a
potential regulatory mechanism whereby CTP, upon binding the
last enzyme of the CoA biosynthetic pathway, prevents the latter’s
interaction with its leading substrate, thereby preventing its
oligomeric transformation to the active form; in effect, limiting
the catalytic efficiency of CoaE (Figure 7). While the data do not
allow us to conclude generality of this regulation, the data
presented here suggest that the tubercular pathogen seems to have
evolved a neat regulatory mechanism at a critical step of central
metabolism which elegantly modulates metabolic flux through this
step of the pathway by subtle changes in the percentage of active
enzyme available, mediated through a barrier lifted only by the
presence of the leading substrate. Thus, the dynamic interplay
between the two oligomeric states of the mycobacterial CoaE
regulates enzyme activity. The organism has further evolved a
second level of regulation via the cellular metabolite CTP which
keeps the oligomeric equilibrium in check. It is tempting to suggest
that analogues of CTP would prove to be promising as inhibitors
of Mycobacterium tuberculosis growth.
The effects of the two ligands, the leading substrate, DCoA and
the modulator, CTP, on the conformation of the mycobacterial
CoaE have been verified through a variety of approaches. The
oligomeric status has been confirmed by DLS measurements and
glutaraldehyde crosslinking experiments both of which show
evidence of a trimeric state. Conformational changes induced
upon the binding of the two ligands have been mapped by limited
proteolysis and fluorescence spectroscopic analysis. However, this
hypothesis needs further verification through detailed structural
analysis of the mycobacterial CoaE.
It is important to note that mycobacterial cellular CoA pools
vary widely in response to various stresses [6,27–28]. For example,
under the stress conditions faced by mycobacteria in the host, such
as a regular onslaught of drugs, whereby the organism shifts to the
latently active persistent state with only a handful metabolic
activities functioning, delicately fine-tuning its CoA stores is
essential for precious energy conservation. Therefore, apart from
the regulation effected via oligomeric re-equilibration between the
inactive and active enzyme forms, the second layer in the
regulatory cascade of CoA generation effected through the
influence of CTP on the oligomeric status of CoaE and thereby
its activity, effectively limiting CoA biosynthesis, has potentially
evolved in mycobacteria to ensure a strict regulation of their
response to stress. Thus these data emphasize that, considering its
role in fine-tuning the levels of the cellular CoA pool by virtue of
two different regulatory processes, the last step of CoA biosynthesis
merits greater attention in the overall regulation of the pathway
than has been previously allocated.
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